Development Level

Tchem 9 | 1,890
Tbio 7 | 10,625
Tclin 7 | 602

Collection

GPCR: IDG Consortium (Targets) 1 | 128

IMPC Phenotype

abnormal head morphology 1 | 10
decreased body weight 1 | 174
decreased circulating HDL chol... 1 | 77
decreased circulating LDL chol... 1 | 37
decreased circulating calcium ... 1 | 33
decreased circulating choleste... 1 | 85
decreased circulating fructosa... 1 | 31
decreased circulating serum al... 1 | 79
decreased circulating total pr... 1 | 41
decreased fasted circulating g... 1 | 49
decreased lumbar vertebrae num... 1 | 62
decreased prepulse inhibition 1 | 52
decreased startle reflex 1 | 48
decreased total body fat amoun... 1 | 186
improved glucose tolerance 1 | 56
increased circulating HDL chol... 1 | 63
increased circulating choleste... 1 | 53
increased circulating fructosa... 1 | 11

Disease

psoriasis 15 | 6,685
glioblastoma 12 | 5,572
medulloblastoma, large-cell 11 | 6,234
osteosarcoma 9 | 7,933
primitive neuroectodermal tumor 9 | 3,031
adult high grade glioma 8 | 2,148
atypical teratoid / rhabdoid tumor 8 | 4,369
pilocytic astrocytoma 8 | 3,086
Schizophrenia 7 | 503
oligodendroglioma 7 | 2,849
ovarian cancer 7 | 8,491
Carcinoma 6 | 2,147
lung cancer 6 | 4,473
lung carcinoma 6 | 2,844
Alcohol dependence 5 | 107
Amphetamine-Related Disorders 5 | 74
Attention deficit hyperactivity disorder 5 | 156
Autistic Disorder 5 | 320
Bipolar Disorder 5 | 266
Breast cancer 5 | 3,098
Epilepsy 5 | 346
Major Depressive Disorder 5 | 106
Parkinson's disease 5 | 364
astrocytoma 5 | 1,493
group 3 medulloblastoma 5 | 2,254
invasive ductal carcinoma 5 | 2,950
posterior fossa group A ependymoma 5 | 1,511
ulcerative colitis 5 | 2,087
Cancer 4 | 2,346
Cocaine-Related Disorders 4 | 88
Gilles de la Tourette syndrome 4 | 47
Nicotine dependence 4 | 53
Substance abuse 4 | 55
atypical teratoid/rhabdoid tumor 4 | 1,095
ependymoma 4 | 2,514
interstitial cystitis 4 | 2,299
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
lung adenocarcinoma 4 | 2,714
subependymal giant cell astrocytoma 4 | 2,287
tuberculosis 4 | 1,563
Asthma 3 | 349
Chronic schizophrenia 3 | 4
Cocaine dependence 3 | 24
Heroin dependence 3 | 30
Hyperactive behavior 3 | 31
Movement Disorders 3 | 21
Multiple myeloma 3 | 1,327
Muscle Spasticity of Cerebral Origin 3 | 8
Muscle spasticity of spinal origin 3 | 8
Narcolepsy 3 | 69
Nasal congestion 3 | 24
Nasal discharge 3 | 26
Obesity 3 | 616
Pathological gambling 3 | 16
Pick disease 3 | 1,893
Restless legs 3 | 5
Seizures 3 | 95
Waldenstrons macroglobulinemia 3 | 764
adrenocortical carcinoma 3 | 1,427
astrocytic glioma 3 | 2,241
ductal carcinoma in situ 3 | 1,745
group 4 medulloblastoma 3 | 1,875
head and neck cancer 3 | 270
malignant mesothelioma 3 | 3,163
non-small cell lung cancer 3 | 2,798
pancreatic cancer 3 | 2,300
pediatric high grade glioma 3 | 2,712
pituitary cancer 3 | 1,972
Acromegaly 2 | 40
Allergic rhinitis 2 | 92
Cerebrovascular disease 2 | 231
Constipation 2 | 43
Delusional disorder 2 | 10
Disruptive, Impulse Control, and Conduct Disorders 2 | 3
Dyskinesia, Drug-Induced 2 | 15
Heart disease 2 | 279
Hyperalgesia 2 | 71
Hypertensive disease 2 | 193
Kidney disease 2 | 397
Mammary Neoplasms 2 | 410
Mental depression 2 | 58
Multiple Sclerosis 2 | 498
Panic disorder 2 | 55
Schizoaffective disorder 2 | 33
Substance-Related Disorders 2 | 114
Toxic encephalopathy 2 | 131
adrenocortical adenoma 2 | 134
breast carcinoma 2 | 1,614
colon cancer 2 | 1,475
cystic fibrosis 2 | 1,670
fibroadenoma 2 | 557
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
hepatocellular carcinoma 2 | 550
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
mucosa-associated lymphoid tissue lymphoma 2 | 480
pancreatic carcinoma 2 | 567
pulmonary arterial hypertension 2 | 36
sonic hedgehog group medulloblastoma 2 | 1,482
tuberculosis and treatment for 3 months 2 | 327

Tissue

Digestive Tract 23 | 18,472
Skin and soft tissues 23 | 18,114
Endocrine System 22 | 18,511
Female tissues 22 | 18,646
Nervous System 22 | 18,560
Urinary Tract 22 | 18,443
Blood and immune system 21 | 17,994
Cardiovascular System 21 | 17,957
Liver and Pancreas 21 | 18,135
Male tissues 21 | 17,968
Respiratory system 19 | 17,483

Target Family

GPCR 18 | 408
Non-IDG 3 | 11,969
Enzyme 1 | 4,146
Kinase 1 | 634

GO Process

negative regulation of adenyla... 23 | 23
transcription, DNA-templated 1,779 | 1,779
regulation of transcription, D... 1,170 | 1,170
signal transduction 969 | 969
positive regulation of transcr... 845 | 845
G-protein coupled receptor sig... 666 | 666
negative regulation of transcr... 620 | 620
apoptotic process 506 | 506
positive regulation of transcr... 504 | 504
negative regulation of transcr... 483 | 483
multicellular organism develop... 456 | 456
positive regulation of cell pr... 451 | 451
cell differentiation 442 | 442
negative regulation of apoptot... 440 | 440
innate immune response 410 | 410
cell adhesion 409 | 409
immune response 398 | 398
negative regulation of cell pr... 379 | 379
inflammatory response 371 | 371
viral process 367 | 367
spermatogenesis 365 | 365
cell proliferation 358 | 358
protein transport 356 | 356
intracellular signal transduct... 355 | 355
cell division 330 | 330
regulation of transcription fr... 324 | 324
protein phosphorylation 320 | 320
response to drug 297 | 297
positive regulation of apoptot... 292 | 292
nervous system development 275 | 275
transcription from RNA polymer... 272 | 272
cell surface receptor signalin... 267 | 267
protein ubiquitination 260 | 260
transport 257 | 257
cell-cell signaling 249 | 249
regulation of immune response 247 | 247
positive regulation of gene ex... 242 | 242
mitotic nuclear division 241 | 241
chemical synaptic transmission 238 | 238
MAPK cascade 237 | 237
mRNA splicing, via spliceosome 219 | 219
angiogenesis 218 | 218
small GTPase mediated signal t... 215 | 215
translation 215 | 215
rRNA processing 209 | 209
intracellular protein transpor... 205 | 205
cellular response to DNA damag... 201 | 201
cell cycle 200 | 200
proteasome-mediated ubiquitin-... 199 | 199
proteolysis 199 | 199
visual perception 198 | 198
DNA repair 196 | 196
extracellular matrix organizat... 193 | 193
regulation of apoptotic proces... 190 | 190
brain development 183 | 183
positive regulation of cell mi... 181 | 181
protein polyubiquitination 180 | 180
in utero embryonic development 178 | 178
Fc-epsilon receptor signaling ... 175 | 175
Wnt signaling pathway 175 | 175
ion transmembrane transport 174 | 174
protein homooligomerization 173 | 173
heart development 170 | 170
positive regulation of ERK1 an... 170 | 170
blood coagulation 169 | 169
cell migration 168 | 168
regulation of cell proliferati... 167 | 167
protein autophosphorylation 166 | 166
response to hypoxia 164 | 164
mRNA processing 162 | 162
protein folding 162 | 162
negative regulation of canonic... 161 | 161
response to lipopolysaccharide 161 | 161
T cell receptor signaling path... 160 | 160
defense response to virus 160 | 160
RNA splicing 158 | 158
aging 158 | 158
positive regulation of I-kappa... 158 | 158
axon guidance 157 | 157
homophilic cell adhesion via p... 155 | 155
sensory perception of smell 155 | 155
ER to Golgi vesicle-mediated t... 151 | 151
interferon-gamma-mediated sign... 150 | 150
protein ubiquitination involve... 150 | 150
transcription initiation from ... 150 | 150
ubiquitin-dependent protein ca... 149 | 149
DNA replication 144 | 144
adaptive immune response 139 | 139
cell cycle arrest 139 | 139
receptor-mediated endocytosis 139 | 139
skeletal system development 136 | 136
regulation of cell shape 135 | 135
regulation of small GTPase med... 134 | 134
G2-M transition of mitotic cel... 133 | 133
oxidation-reduction process 133 | 133
positive regulation of cytosol... 133 | 133
protein stabilization 133 | 133
sensory perception of sound 132 | 132
positive regulation of NF-kapp... 131 | 131
type I interferon signaling pa... 130 | 130
endocytosis 129 | 129

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
D(2) dopamine receptor DRD2 Tclin GPCR -3.26127 1775.2 248
Galanin receptor type 2 GALR2 Tchem GPCR -1.88843 67.4 195
Guanine nucleotide-binding protein G(i) subunit alpha-2 GNAI2 Tbio Non-IDG -1.25323 16.6 188
Protein kinase C alpha type PRKCA Tchem Kinase -2.39992 212.2 774
Metabotropic glutamate receptor 2 GRM2 Tchem GPCR -2.74553 574.9 269
Galanin receptor type 3 GALR3 Tchem GPCR -1.47251 20.8 167
D(3) dopamine receptor DRD3 Tclin GPCR -2.49894 303.4 169
Mu-type opioid receptor OPRM1 Tclin GPCR -3.22199 1609.2 372
Paralemmin-1 PALM Tbio Non-IDG -1.24016 16.7 50
D(4) dopamine receptor DRD4 Tchem GPCR -2.85888 707.1 334